NASH Trials in Columbus
Centricity Research is currently participating in several NASH studies at our Columbus, Ohio location. When liver cells store too much fat, the liver becomes inflamed and damaged. This is commonly the result of years of alcohol abuse, but a growing number of people are being diagnosed with a similar issue without heavy drinking. The term for this condition is nonalcoholic fatty liver disease, and it affects an estimated 80 to 100 million people. Nonalcoholic steatohepatitis, or NASH, is the most severe form of the disease. Once the condition reaches this stage, it can lead to scarring, fibrosis, liver cancer, cirrhosis, or liver failure.
NASH is linked to overweight or obesity, insulin resistance, high blood sugar, and high levels of fats in the blood. While some people experience fatigue or pain or swelling in the abdomen, most people do not display any symptoms, making NASH difficult to diagnose.
Learn more about this study and search protocol HEPA-CTR431-207 and 337HNAS20011 at clinicaltrials.gov
Centricity Research also offers free liver screenings called Fibroscan. The Fibroscan screening is completely free and health insurance is not required.
Ready to Volunteer?
Volunteer today to see if you qualify for our NASH clinical research study. Qualified volunteers may be compensated for time and travel.